GlaxoSmithKline PLC News http://iii/investment/detail?code=cotn:GSK.L&display=news African states set to receive H1N1 vaccine soon-WHO http://www.iii.co.uk/investment/detail?code=cotn:GSK.L&display=news&action=article&articleid=7801486&from=rss GENEVA, March 19 (Reuters) - The World Health Organisation (WHO) said on Friday it would deliver millions of H1N1 vaccine doses to about a dozen countries in Africa in coming weeks. Nigeria, Africa's most populous country, as well as Kenya and South Africa are among those slated to receive vaccine... Fri, 19 Mar 2010 13:18:00 GMT Many Avandia defenders have drug co. ties -study http://www.iii.co.uk/investment/detail?code=cotn:GSK.L&display=news&action=article&articleid=7800449&from=rss By Julie Steenhuysen CHICAGO, March 18 (Reuters) - Virtually all of the experts who wrote favorably about GlaxoSmithKline Plc's troubled diabetes drug Avandia had financial ties to drug makers, a finding that shows the need for reform of such relationships, U.S. researchers said on Thursday. ... Fri, 19 Mar 2010 00:15:00 GMT New collaboration aims to speed TB drugs to market http://www.iii.co.uk/investment/detail?code=cotn:GSK.L&display=news&action=article&articleid=7800406&from=rss By Maggie Fox, Health and Science Editor WASHINGTON, March 18 (Reuters) - U.S. regulators, drug companies, philanthropists and advocates announced a new alliance on Thursday to speed tuberculosis drugs to market, a day after cancer researchers and drugmakers launched a similar initiative. The... Thu, 18 Mar 2010 22:36:00 GMT BRIEF-Pfizer R&D head: still on target for drug filings http://www.iii.co.uk/investment/detail?code=cotn:GSK.L&display=news&action=article&articleid=7799692&from=rss LONDON, March 18 (Reuters) - Martin Mackay, Pfizer's President of PharmaTherapeutics Research & Development, tells Reuters: * Still on track to make 15-20 regulatory filings in 2010-12 from legacy Pfizer pipeline * Pain drug tanezumab, JAK3 inhibitor arthritis drug and heart drug apixaban seen as... Thu, 18 Mar 2010 14:55:00 GMT US FDA staff: may need wider eczema caution for kids http://www.iii.co.uk/investment/detail?code=cotn:GSK.L&display=news&action=article&articleid=7799593&from=rss WASHINGTON, March 18 (Reuters) - Novartis AG and Astellas Pharma eczema drugs may need their warning labels expanded after dozens of new reported cases of cancer and infection in children, U.S. Food and Drug Administration staff said in documents released on Thursday. Agency scientists said... Thu, 18 Mar 2010 14:21:00 GMT US FDA staff: may need wider eczema caution for kids http://www.iii.co.uk/investment/detail?code=cotn:GSK.L&display=news&action=article&articleid=7799587&from=rss WASHINGTON, March 18 (Reuters) - Novartis AG and Astellas Pharma eczema drugs may need their warning labels expanded after dozens of new reported cases of cancer and infection in children, U.S. Food and Drug Administration staff said in documents released on Thursday. Agency scientists said... Thu, 18 Mar 2010 14:20:00 GMT BRIEF-US FDA staff: Novartis, Astellas eczema drugs may need wider warnings http://www.iii.co.uk/investment/detail?code=cotn:GSK.L&display=news&action=article&articleid=7799469&from=rss WASHINGTON, March 18 (Reuters) - U.S. Food and Drug Administration staff, in documents released on Thursday, said: * New post-marketing side effects have been reported in children using Novartis AG and Astellas Pharma eczema drugs: 46 cancer cases, 71 infection cases * Despite black... Thu, 18 Mar 2010 13:31:00 GMT UPDATE 2-Glaxo up as Novartis drops generic Advair in U.S. http://www.iii.co.uk/investment/detail?code=cotn:GSK.L&display=news&action=article&articleid=7798983&from=rss By Ben Hirschler LONDON, March 18 (Reuters) - Novartis has handed back U.S. rights to a drug widely believed to be a generic version of GlaxoSmithKline's lung blockbuster Advair, reducing the risk of cheap copies in Glaxo's biggest market. The decision on VR315, which Novartis's generics arm... Thu, 18 Mar 2010 10:47:00 GMT PRESS DIGEST - Canada - March 18 http://www.iii.co.uk/investment/detail?code=cotn:GSK.L&display=news&action=article&articleid=7798942&from=rss March 18 (Reuters) - The following are top stories from selected Canadian newspapers. Reuters has not verified these stories and does not vouch for their accuracy. THE GLOBE AND MAIL: - After years of controversies, mishaps and upheaval, the RCMP is headed for a major shift at... Thu, 18 Mar 2010 10:30:00 GMT PRESS DIGEST - Canada - March 17 http://www.iii.co.uk/investment/detail?code=cotn:GSK.L&display=news&action=article&articleid=7798938&from=rss March 17 (Reuters) - The following are top stories from selected Canadian newspapers. Reuters has not verified these stories and does not vouch for their accuracy. THE GLOBE AND MAIL: - Canada and its allies have repeatedly promised -- and failed -- to build a new prison in Afghanistan... Thu, 18 Mar 2010 10:28:00 GMT UPDATE 1-Glaxo up as Novartis drops generic Advair in U.S. http://www.iii.co.uk/investment/detail?code=cotn:GSK.L&display=news&action=article&articleid=7798816&from=rss By Ben Hirschler LONDON, March 18 (Reuters) - Novartis has handed back U.S. rights to a drug widely believed to be a generic copy of GlaxoSmithKline's lung blockbuster Advair, reducing the risk of cheap copies in Glaxo's biggest market. The decision on VR315, which Novartis's generics arm Sandoz... Thu, 18 Mar 2010 09:43:00 GMT UPDATE 3-U.S. senator asks drugmakers to explain prices http://www.iii.co.uk/investment/detail?code=cotn:GSK.L&display=news&action=article&articleid=7798128&from=rss WASHINGTON, March 17 (Reuters) - A U.S. Senate Democrat asked top drugmakers on Wednesday to explain why Americans pay higher prices for prescription drugs than patients do in other developed nations. Senator Herb Kohl, who chairs the Special Committee on Aging, sent letters to AstraZeneca, GlaxoSmithKline... Wed, 17 Mar 2010 23:58:00 GMT UPDATE 2-U.S. senator asks drugmakers to explain prices http://www.iii.co.uk/investment/detail?code=cotn:GSK.L&display=news&action=article&articleid=7798021&from=rss WASHINGTON, March 17 (Reuters) - A U.S. Senate Democrat asked top drugmakers on Wednesday to explain why Americans pay higher prices for prescription drugs than patients do in other developed nations. Senator Herb Kohl, who chairs the Special Committee on Aging, sent letters to AstraZeneca, GlaxoSmithKline... Wed, 17 Mar 2010 21:13:00 GMT BRIEF-Theravance comments on Relovair program http://www.iii.co.uk/investment/detail?code=cotn:GSK.L&display=news&action=article&articleid=7797989&from=rss March 17 (Reuters) - Theravance Inc: * Uncertainty regarding FDA's position on labas may result in higher time, cost of relovair trials in U.S. * Uncertainty may increase the overall risk of the Relovair asthma program in U.S. - SEC filing ((Bangalore Equities Newsroom; +91 80 4135... Wed, 17 Mar 2010 20:42:00 GMT U.S. FDA advisory meetings through May 12 http://www.iii.co.uk/investment/detail?code=cotn:GSK.L&display=news&action=article&articleid=7797810&from=rss THIS DIARY IS FILED AS THE FOOD AND DRUG ADMINISTRATION UPDATES ITS SCHEDULE. ALL ITEMS ARE EDT/GMT. For more information on the FDA's Advisory Committee meetings, see: http://www.fda.gov/AdvisoryCommittees/Calendar/default.htm (Adds April 12 blood products meeting, April 22... Wed, 17 Mar 2010 17:43:00 GMT U.S. FDA advisory meetings through May 12 http://www.iii.co.uk/investment/detail?code=cotn:GSK.L&display=news&action=article&articleid=7797808&from=rss THIS DIARY IS FILED AS THE FOOD AND DRUG ADMINISTRATION UPDATES ITS SCHEDULE. ALL ITEMS ARE EDT/GMT. For more information on the FDA's Advisory Committee meetings, see: http://www.fda.gov/AdvisoryCommittees/Calendar/default.htm (Adds April 12 blood products meeting, April 22... Wed, 17 Mar 2010 17:41:00 GMT U.S. FDA advisory meetings through May 12 http://www.iii.co.uk/investment/detail?code=cotn:GSK.L&display=news&action=article&articleid=7797803&from=rss THIS DIARY IS FILED AS THE FOOD AND DRUG ADMINISTRATION UPDATES ITS SCHEDULE. ALL ITEMS ARE EDT/GMT. For more information on the FDA's Advisory Committee meetings, see: http://www.fda.gov/AdvisoryCommittees/Calendar/default.htm (Adds April 12 blood products meeting, April 22... Wed, 17 Mar 2010 17:40:00 GMT UPDATE 1-U.S. senator asks drugmakers to explain prices http://www.iii.co.uk/investment/detail?code=cotn:GSK.L&display=news&action=article&articleid=7797702&from=rss WASHINGTON, March 17 (Reuters) - A U.S. Senate Democrat asked top drugmakers on Wednesday to explain why Americans pay higher prices for prescription drugs than patients do in other developed nations. Senator Herb Kohl, who chairs the Special Committee on Aging, sent letters to AstraZeneca, GlaxoSmithKline... Wed, 17 Mar 2010 16:45:00 GMT BRIEF-U.S. senator ask drugmakers to explain higher U.S. prices http://www.iii.co.uk/investment/detail?code=cotn:GSK.L&display=news&action=article&articleid=7797656&from=rss WASHINGTON, March 17 (Reuters) - U.S. Senator Herb Kohl, a Democrat, said in a statement on Wednesday: * senator sent letters to drugmakers asking them to explain why Americans pay 'an average of twice as much for prescription drugs as other industrialized nations' * Letters about drug... Wed, 17 Mar 2010 16:20:00 GMT Antidepressants can help people with physical ills http://www.iii.co.uk/investment/detail?code=cotn:GSK.L&display=news&action=article&articleid=7795859&from=rss LONDON, March 17 (Reuters) - Antidepressants such as Eli Lilly's Prozac or GlaxoSmithKline's Paxil can help depressed patients with physical illness, and doctors should consider them more often, researchers said on Wednesday. While around 10 percent of patients with physical diseases are thought... Wed, 17 Mar 2010 00:16:00 GMT